Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Gema, Bruixola"'
Publikováno v:
ESMO Open, Vol 5, Iss 5 (2020)
Externí odkaz:
https://doaj.org/article/b9d9415614654db6a20ba7fed9547259
Publikováno v:
ESMO Open, Vol 4, Iss 4 (2019)
Externí odkaz:
https://doaj.org/article/8dcb1074991c43049aa45a8226781d8d
Autor:
Gema Bruixola, Ángel Segura, Javier Caballero, Ana Andrés, Encarnación Reche, Corina Escoín, Roberto Díaz-Beveridge
Publikováno v:
Case Reports in Oncology, Vol 7, Iss 2, Pp 591-599 (2014)
Background: Cardiac metastases from papillary thyroid carcinoma are very uncommon. Their incidence is rising due to improvements in survival and diagnosis; nevertheless, our patient is the fourth case reported up to date. There are no clinical trials
Externí odkaz:
https://doaj.org/article/f696de4e15ff4745a045fd0cf00601ec
Autor:
Santiago, Mercadal, Mónica, Alañá, María Ines, Barceló, Gema, Bruixola, Patricia, López-Pereira, Sabela, Bobillo, Ivan, Dlouhy, Rocío Caldú, Agud, Estefanía García, Molina, Pilar, Martínez, Purificación, Cacabelos, Ana, Muntañola, Guillermo, García-Catalán, Juan Manuel, Sancho, Iria, Campos, Tamara, Lado, Antonio, Salar, Ana Carolina, Caballero, María, Solé-Rodríguez, Roser, Velasco
Publikováno v:
British journal of haematologyREFERENCES. 197(6)
Autor:
Angel Segura Huerta, Encarnación Reche Santos, Gema Bruixola Campos, Carmen Salvador Coloma, Oscar Niño Gómez
Publikováno v:
Case Reports in Oncology, Vol 6, Iss 2, Pp 391-396 (2013)
Introduction: To date, there are no guidelines for a rational and more favourable sequence of treatment after docetaxel. Two drugs (cabazitaxel and abiraterone) have recently been approved as second-line treatment after docetaxel failure in metastati
Externí odkaz:
https://doaj.org/article/201f290226824043b29bfa2930d60af4
Publikováno v:
Ann Transl Med
OBJECTIVE: To perform a narrative review of the prognostic value of prognostic nutritional index (PNI) in cancers. BACKGROUND: Prognostic estimation greatly determines the treatment approach in various cancers. The PNI, calculated using the serum alb
Autor:
Julio Jose Lambea Sorrosal, Gema Bruixola, Javier Martinez-Trufero, Beatriz Cirauqui, Almudena García Castaño, Javier Caballero Daroqui, Jordi Rubió-Casadevall, Ricard Mesia, Pedro Perez, Alberto Carral, Vanesa Gutierrez Calderon, Edel del Barco, Joaquina Martínez-Galán, Marc Oliva Bernal, Laura Basterretxea, Virginia Arrazubi, Lara Iglesias, Ruth Alvarez, Ana Medina, Neus Basté Rotllán, Neck Cancer Treatment
Publikováno v:
Journal of Clinical Oncology. 39:TPS6086-TPS6086
TPS6086 Background: Nivolumab is the standard of care for patients (pts) with R/M HNSCC in the platinum-refractory setting. Up to 20% of R/M HNSCC pts are ineligible for cisplatin-based CT due to poor performance status and/or comorbidities. ERBITAX
Publikováno v:
Medical Oncology. 34
Neoadjuvant radiotherapy previous to radical surgery, both as short-course radiotherapy and as long-course radiotherapy combined with 5-FU-based chemotherapy (LCRCT), is routinely used in the management of locally advanced rectal cancer, with consist
Autor:
Enrique Jiménez, Jorge Aparicio, Gema Bruixola, Corina Escoin, Miguel Salavert, Robert Diaz-Beveridge, Javier Caballero
Publikováno v:
Lung Cancer. 86:105-111
Pleuropulmonary angiosarcomas are very rare, with less than fifty cases reported in the literature. In most cases, the etiology is unknown but the presence of a chronic tuberculous pyothorax has been reported in several Asian case reports as a possib
Autor:
Corina Escoin, Gema Bruixola, Ángel Segura, Javier Caballero, E. Reche, Ana Andrés, Roberto Díaz-Beveridge
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 7, Iss 2, Pp 591-599 (2014)
Case Reports in Oncology, Vol 7, Iss 2, Pp 591-599 (2014)
Background: Cardiac metastases from papillary thyroid carcinoma are very uncommon. Their incidence is rising due to improvements in survival and diagnosis; nevertheless, our patient is the fourth case reported up to date. There are no clinical trials